Clinical Trial Update: Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen [Phase 1]

View source ↗

Summary

A Phase 1 randomized trial in liver transplant recipients evaluating a steroid-sparing immunosuppressive regimen has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Duke University | Conditions: Chronic Hepatitis C, Organ Transplantation | Phase 1 | Status: COMPLETED